Global Amniocentesis Needles Market Analysis
Amniocentesis is a pregnancy test that involves removing a small volume of amniotic fluid from the sac containing the fetus. The procedure is used to identify genetic abnormalities, determine sex, and determine paternity. According to a 2016 survey by the American Pregnancy Association (APA), the amniocentesis test is 99.4 percent reliable. Amniocentesis needles come in a variety of sizes, from 20 G (gauge), 21 G, and 22 G to 29 G. For a typical Body Mass Index (BMI) of a pregnant woman ranging from 18.5 kg/m2 to 24.9 kg/m2, the most appropriate needle for amniocentesis testing is 20 G to 22 G. Most maternity clinics advise mothers above the age of 35 to undergo an amniocentesis procedure. According to research released in 2017 by UT Southwestern Medical Centre, women over the age of 35 are more likely to give birth to a child with Down syndrome.
In 2018, the global amniocentesis needles market was worth US$ 154.4 million, and it is projected to develop at a CAGR of 3.8 percent from 2019 to 2026.
Get FREE Sample PDF Including COVID-19 Impact Analysis: https://www.coherentmarketinsights.com/insight/request-pdf/2624
The global amniocentesis needles market is expected to grow due to increased research and development for new applications of amniocentesis.
Due to the rising demand for amniocentesis, the global amniocentesis needles market is expected to grow rapidly, necessitating further research and development of new techniques and applications. Complete Genomics researchers in San Jose, California, demonstrated in 2018 that amniocentesis along with whole-genome sequencing (WGS) can be used to test a fetus’ whole genome for adverse mutations. The researchers took mucus from 31 pregnant women and extracted DNA from the fluid as well as the fetal cells contained within it. The researchers discovered that WGS accurately calculated up to 97 percent of the fetal genome.
Furthermore, increased understanding of women’s and children’s well-being necessitates the use of an amniocentesis examination. According to a 2016 survey from the University Hospital of Southampton, over 15,000 women in the United Kingdom undergo an amniocentesis procedure each year to learn about their child’s welfare.
Buy Now with Discount for Premium Report 2021: https://www.coherentmarketinsights.com/promo/buynow/2624
The range of available testing for amniocentesis is a major restraint on the global amniocentesis needles market’s expansion. Non-invasive prenatal testing (NIPT), first trimester combined screening, second trimester quad scan, and integrated screening are some of the other options. The global amniocentesis needle market is being hampered by patient acceptance of NIPT, which is associated with less incision, less discomfort, and faster recovery. As per data released in Clinical Chemistry Journal in 2017, many U.S. and international clinical laboratories have approved the intellectual property required to incorporate NIPT in as many as 15 U.S. laboratories. In 2017, almost 3000 women were tested in the U.S., with tests provided at no cost to the woman.
Due to the rising number of tests conducted each year, North America is predicted to maintain a leading spot in the global amniocentesis needles market. Around 200,000 amniocentesis experiments are conducted in the U.S. each year, according to figures from the Health Research Funding Organization.
Due to increasing government interventions and reimbursement programs for amniocentesis studies, the European amniocentesis needles market is expected to expand rapidly during the forecast period. As per statistics released in Patients Platform Limited in 2016, approximately 5% of pregnant women (roughly 30,000 women in the U.K.) are given a free invasive prenatal screening procedure, typically amniocentesis or chorionic villus sampling (CVS).
View Press Release For More Information @ https://www.coherentmarketinsights.com/press-release/amniocentesis-needles-market-to-surpass-us-2086-million-by-2026-1399
Major companies contributing in the global amniocentesis needles market are Laboratoire CCD, Integra Lifesciences, RI.MOS.S.R.L., Biopsybell S.R.L., Dickinson and Company, Becton, Smiths Medical Inc., Tsunami Medical S.R.L., CooperSurgical Inc., Cook Medical Inc, Rocket Medical Plc., Medtronic Plc, and Medline Industries Inc.
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027